On February 26, 2026, the People's Bank of China ("PBoC") promulgated the Notice on Relevant Matters Concerning Cross-border RMB Interbank Financing Business of Banking Financial Institutions (Yin Fa [2026] No. 51, the "Notice"). Previously, on September 12, 2025, the PBoC issued the Notice of the PBoC on Relevant Matters Concerning Cross-border RMB Interbank Financing Business of Banking Financial Institutions (Draft for Comments) (the "Draft"). The Notice further optimizes and relaxes the relevant conditions on the basis of the Draft, including: expanding the business quota for foreign-funded banks; removing the universal restriction that financing tenor shall be within one(1) year,; adding several circumstances which are excluded from the calculation of net lending balance; and expanding the scope of application to a wider range of financial institutions.

In 2026, the Beijing Financial Court and the High People's Court of Beijing Municipality（"Beijing High People's Court"）ruled that Chinese mainland courts had jurisdiction over securities fraud involving a Cayman Islands company listed on the Hong Kong Stock Exchange (HKEX). This landmark decision sets a precedent as the first instance in which judicial authorities in Chinese mainland applied the Securities Law of the PRC (the "Securities Law") extraterritorially. The decision is recognized as a "typical case" and has been included in the Report on the Work of the Supreme People's Court (2026). Its importance is exemplified by an April 20, 2026, media interview in which Judge Ding Yuxiang, Chief Judge of the Second Civil Division of the Beijing Financial Court, reaffirmed the court's view that "Article 2, Paragraph 4 of the Securities Law can be invoked whenever the lawful rights and interests of domestic investors are damaged".

On May 8, 2026, the National Health Commission ("NHC") released the Implementing Rules for the Administrative Regulation on Human Genetic Resources (Draft for Comments) ("Draft for Comments"), proposing amendments to the current Implementing Rules for the Administrative Regulation on Human Genetic Resources ("Current Implementing Rules") formulated by the Ministry of Science and Technology ("MOST") in 2023 (for our interpretation of the Current Implementing Rules, please see our previous article: Han Kun Perspective | First Release: Key Takeaways from the Implementing Rules for the Administrative Regulation on Human Genetic Resources), and is soliciting public comments.